These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1825820)
21. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161 [TBL] [Abstract][Full Text] [Related]
22. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Nuttall GA; Murray MJ; Bowie EJ Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and thromboxane A2/prostaglandin H2 receptor antagonistic activity of phenol derivatives. Fukumoto S; Shiraishi M; Terashita Z; Ashida Y; Inada Y J Med Chem; 1992 Jun; 35(12):2202-9. PubMed ID: 1535377 [TBL] [Abstract][Full Text] [Related]
24. Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist. Perzborn E; Fiedler VB; Seuter F; Stasch JP; Weber H; Sander E; Böshagen H; Rosentreter U Stroke; 1990 Dec; 21(12 Suppl):IV143-5. PubMed ID: 2148034 [TBL] [Abstract][Full Text] [Related]
25. The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor. Imura Y; Terashita Z; Shibouta Y; Nishikawa K Eur J Pharmacol; 1988 Mar; 147(3):359-65. PubMed ID: 2967770 [TBL] [Abstract][Full Text] [Related]
26. [Comparative study of the antithrombotic effect of aspirin and Bay U3405, antagonist of a thromboxane A2 receptor]. Cissé-Thiam M; Drouet L Dakar Med; 1999; 44(1):25-7. PubMed ID: 10797981 [TBL] [Abstract][Full Text] [Related]
27. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo. Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979 [TBL] [Abstract][Full Text] [Related]
28. Effects of terbogrel on platelet function and prostaglandin endoperoxide transfer. Muck S; Weber AA; Schrör K Eur J Pharmacol; 1998 Feb; 344(1):45-8. PubMed ID: 9570446 [TBL] [Abstract][Full Text] [Related]
29. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Nakashima S; Koike T; Nozawa Y Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148 [TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamics and antithrombotic effects after intravenous administration of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Depin JC; Vigié A; Chavernac G; Rousselot C; Lardy C; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1203-7. PubMed ID: 7848332 [TBL] [Abstract][Full Text] [Related]
31. The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. Ford-Hutchinson AW; Girard Y; Lord A; Jones TR; Cirino M; Evans JF; Gillard J; Hamel P; Leveillé C; Masson P Can J Physiol Pharmacol; 1989 Sep; 67(9):989-93. PubMed ID: 2598135 [TBL] [Abstract][Full Text] [Related]
32. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG; Dellweg H; Perzborn E; Gross R Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312 [TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721 [TBL] [Abstract][Full Text] [Related]
35. On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist. Ritter JM; Doktor HS; Benjamin N; Barrow SE; Stewart-Long P Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():351-4. PubMed ID: 1825568 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]